Posts by: Margarida Maia PhD

Mynd Diagnostics is launching a clinical study to test the ability of a blood biomarker, which the company coined Mynd anti-inflammatory peptide (MAP), to help in the diagnosis and monitoring ... Read more

November 22, 2021November 22, 2021

COVID-19 Vaccine Side Effects With MS Similar to Public at Large

COVID-19 News, Multiple Sclerosis News Today

Side effects upon receiving the COVID-19 vaccine in people with multiple sclerosis (MS) are similar to those reported in the general population, and patients on certain disease-modifying therapies are less likely ... Read more

November 17, 2021November 17, 2021

Bronchitol–Pulmozyme Combo Better Than Pulmozyme Alone to Clear Kids’ Lungs

Cystic Fibrosis News Today

Bronchitol (mannitol) plus Pulmozyme (dornase alfa) is better than Pulmozyne alone to help loosen mucus in the lungs in children with cystic fibrosis (CF), and this seems to translate into better lung function. The study ... Read more

November 16, 2021November 16, 2021

Catalyst Will Seek FDA Approval of Firdapse for Children

Lambert-Eaton News

Catalyst Pharmaceuticals plans to file an application with the U.S. Food and Drug Administration (FDA) requesting that the use of Firdapse (amifampridine), an approved oral therapy for adults with Lambert-Eaton myasthenic ... Read more

November 15, 2021November 15, 2021

Study Finds PTH Needs Another Hormone to Help Lower Phosphate Levels

Hypoparathyroidism News

Replacement therapy with parathyroid hormone (PTH) — the hormone found at low levels in patients with hypoparathyroidism — requires the presence of another hormone called fibroblast growth factor 23 (FGF23) ... Read more

November 15, 2021November 16, 2021

Simple, Low-cost Tests May Help Identify Undiagnosed COPD in China

COPD News Today

Low-cost screening involving a questionnaire and a breathing test may help identify patients with undiagnosed chronic obstructive pulmonary disease (COPD), a study conducted in China has found. Among the combinations ... Read more

November 12, 2021November 12, 2021

Omalizumab May Be Effective, Safe for RDEB With High IgE Levels

Epidermolysis Bullosa News

Omalizumab — an antibody against immunoglobulin E (IgE) — may be effective and safe for wound healing in patients with recessive dystrophic epidermolysis bullosa (RDEB) and high IgE levels, a small ... Read more

November 12, 2021November 12, 2021

TQS-168 Found to Reduce Inflammation, Extend Survival in Mice

ALS News Today

TQS-168, an investigational therapy being developed by Tranquis Therapeutics, reduced inflammation in mouse and human models of amyotrophic lateral sclerosis (ALS), and prolonged survival in the mice, according to a ... Read more

November 12, 2021November 12, 2021

Targeted Gene Therapy Boosts Levodopa’s Benefits in Mouse Study

Parkinson's News Today

A gene therapy targeting the substantia nigra, the brain region with dopamine-producing nerve cells, may boost the benefits of levodopa for people with Parkinson’s disease, a study reports. This idea was ... Read more

November 8, 2021November 8, 2021

With PAH, Local Anesthesia Better Than General for Mother and Baby

Pulmonary Hypertension News

Local anesthesia is better than general anesthesia for both the mother and her baby when delivery is by cesarean section (C-section) and the woman has pulmonary arterial hypertension (PAH), a study ... Read more

November 8, 2021November 8, 2021

High Levels of IL-35, a Signaling Molecule, May Slow PF Progression

Pulmonary Fibrosis News

A signaling molecule called interleukin 35 (IL-35) is at unusually high levels in lung tissues from mice and in people with pulmonary fibrosis (PF), and seems to play a role ... Read more

November 5, 2021November 6, 2021

Krystal Completes Phase 3 Trial of B-VEC, Topical Gene Therapy for DEB

Epidermolysis Bullosa News

Topline data should be available toward the end of this year for a Phase 3 clinical trial testing B-VEC (beremagene geperpavec), a topical gene therapy for treating skin wounds in patients ... Read more

November 5, 2021November 6, 2021

CFF Investing Up to $110M, Partnering to Advance Gene Therapy

Cystic Fibrosis News Today

The Cystic Fibrosis Foundation (CFF) is partnering with Pioneering Medicines, an initiative of Flagship Pioneering, to support the development of various types of gene therapy for cystic fibrosis (CF). The foundation is ready ... Read more

November 4, 2021November 4, 2021

Diabetes May Be Immune System Trigger in MG, Worsening Symptoms

Myasthenia Gravis News

Diabetes, which causes blood sugar levels to rise abnormally, may trigger a stronger immune response and worsen myasthenia gravis (MG) symptoms, a study in a rat disease model suggests. If ... Read more

November 4, 2021November 4, 2021

Analysis Finds Acthar Gel Cost-effective for MS Relapses

Multiple Sclerosis News Today

Acthar Gel (repository corticotropin injection) was found to be a cost-effective treatment for people with multiple sclerosis (MS) experiencing a relapse, according to an economic analysis. Notably, the economic value ... Read more